Indefinite passive immunization after liver transplantation for hepatitis B.

Abstract

Liver TransplantationVolume 8, Issue 10B p. s88-s89 Debate Iii—Hepatitis B ImmunoglobulinFree Access Indefinite passive immunization after liver transplantation for hepatitis B Timothy Pruett MD, Corresponding Author Timothy Pruett MD [email protected] University of Virginia Health System, Charlottesville, VAUniversity of Virginia Health System, Charlottesville, VA. Telephone: 434-924-9462; FAX: 434-924-5539Search for more papers by this author Timothy Pruett MD, Corresponding Author Timothy Pruett MD [email protected] University of Virginia Health System, Charlottesville, VAUniversity of Virginia Health System, Charlottesville, VA. Telephone: 434-924-9462; FAX: 434-924-5539Search for more papers by this author First published: 30 December 2003 https://doi.org/10.1053/jlts.2002.35858Citations: 4AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 Yotsuyanagi H, Yasuda K, Iino S, Moriya K, Shintani Y, Fujie H, et al. Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology 1998; 27: 1377– 1382. 2 Marusawa H, Uemoto S, Hijikata M, Ueda Y, Tanaka K, Shimotohno K, Chiba T. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 2000; 31: 488– 495. 3 Noborg U, Gusdal A, Horal P, Lindh M. Levels of viraemia in subjects with serological markers of past or chronic hepatitis B virus infection. Scand J Infect Dis 2000; 32: 249– 252. 4 Blackberg J, Kidd-Ljunggren K. Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation. J Hepatol 2000; 336: 992– 997. 5 Kawatani T, Suou T, Tajima F, Ishiga K, Omura H, Endo A, et al. Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies. Eur J Haematol 2001; 67: 45– 50. 6 Marusawa H, Imoto S, Ueda Y, Chiba T. Reactivation of latently infected hepatitis B virus in a leukemia patient with antibodies to hepatitis B core antigen. J Gastroenterol 2001; 36: 633– 636. 7 Marzano A, Salizzoni M, Debernardi-Venon W, Smedile A, Franchello A, Ciancio A, et al. Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis. J Hepatol 2001; 34: 903– 910. 8 Naoumov NV, Lopes AR, Burra P, Caccamo L, Iemmolo RM, de Man RA, et al. Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation. J Hepatol 2001; 46: 888– 894. Citing Literature Volume8, Issue10BSupplement: Liver Transplantation for Viral Hepatitis From the November 1,2002, AASLD/ILTS Transplant Course Sheraton Hotel, Boston, MAOctober 2002Pages s88-s89 ReferencesRelatedInformation